Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

Relapse is a major cause of treatment failure after allogeneic hematopoietic stem-cell transplantation (allo-HSCT) for high-risk acute myeloid leukemia (HR-AML). The aim of this study was to explore the effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) combined with minimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lei, Zhang, Yanqi, Wang, Sanbin, Kong, Peiyan, Su, Yi, Hu, Jiong, Jiang, Ming, Bai, Hai, Lang, Tao, Wang, Jishi, Liu, Li, Yang, Tonghua, Huang, Xiaobing, Liu, Fang, Lou, Shifeng, Liu, Yao, Zhang, Cheng, Liu, Hong, Gao, Li, Liu, Jia, Zhu, Lidan, Wen, Qin, Chen, Ting, Wang, Ping, Rao, Jun, Mao, Min, Wang, Cunbang, Duan, Xianlin, Luo, Le, Peng, Xiangui, Cassady, Kaniel, Zhong, Jiang F., Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768335/
https://www.ncbi.nlm.nih.gov/pubmed/33108244
http://dx.doi.org/10.1200/JCO.19.03277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768335/
https://www.ncbi.nlm.nih.gov/pubmed/33108244
http://dx.doi.org/10.1200/JCO.19.03277

Ejemplares similares